BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7399333)

  • 21. Combined surgical and radiation therapy for invasive carcinoma of the cervix.
    Kelso JW; Funnell JD; Puckett TG; Strebel GF
    South Med J; 1979 Jun; 72(6):648-51. PubMed ID: 451644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinicopathologic characteristics and risk factors for lung metastasis after radical hysterectomy in early-stage cervical cancer].
    Zheng A; Chen Y; Fang J; Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):204-9. PubMed ID: 26268411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
    Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors.
    Uno T; Ito H; Itami J; Yasuda S; Isobe K; Hara R; Sato T; Minoura S; Shigematsu N; Kubo A
    Anticancer Res; 2000; 20(3B):2235-9. PubMed ID: 10928184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a Gynecologic Oncology Group study).
    Berman ML; Keys H; Creasman W; DiSaia P; Bundy B; Blessing J
    Gynecol Oncol; 1984 Sep; 19(1):8-16. PubMed ID: 6469092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival of women with microinvasive adenocarcinoma of the cervix is not improved by radical surgery.
    Bean LM; Ward KK; Plaxe SC; McHale MT
    Am J Obstet Gynecol; 2017 Sep; 217(3):332.e1-332.e6. PubMed ID: 28522318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carcinoma of the cervix: A third treatment.
    Quigley MM; Knab DR; Mcmahon EB
    Obstet Gynecol; 1975 Jun; 45(6):650-5. PubMed ID: 1143726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can pelvic lymphadenectomy be omitted in stage IA2 to IIB uterine cervical cancer?
    Togami S; Kamio M; Yanazume S; Yoshinaga M; Douchi T
    Int J Gynecol Cancer; 2014 Jul; 24(6):1072-6. PubMed ID: 24905616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Site of recurrence of cervical cancer after radical hysterectomy.
    Webb MJ; Symmonds RE
    Am J Obstet Gynecol; 1980 Dec; 138(7 Pt 1):813-7. PubMed ID: 7446614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radical surgery combined with radiotherapy in the treatment of cervical carcinoma.
    Nieminen U; Mattsson T; Widholm O
    Ann Chir Gynaecol Fenn; 1974; 63(2):134-40. PubMed ID: 4854004
    [No Abstract]   [Full Text] [Related]  

  • 31. Simultaneous modulated accelerated radiotherapy in cervical cancer with retroperitoneal lymph node metastasis after radical hysterectomy and pelvic lymphadenectomy.
    Li XL; Chen ZY; Cui YC; Sheng XG
    Int J Gynecol Cancer; 2015 Jun; 25(5):903-9. PubMed ID: 25822099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-port laparoscopic pelvic lymph node dissection with modified radical vaginal hysterectomy in cervical cancer.
    Hahn HS; Kim YW
    Int J Gynecol Cancer; 2010 Nov; 20(8):1429-32. PubMed ID: 21051989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma.
    Piver MS; Chung WS
    Obstet Gynecol; 1975 Nov; 46(5):507-10. PubMed ID: 1196552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study.
    Sedlis A; Bundy BN; Rotman MZ; Lentz SS; Muderspach LI; Zaino RJ
    Gynecol Oncol; 1999 May; 73(2):177-83. PubMed ID: 10329031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation of histologic factors to the response of stage I epidermoid carcinoma of the cervix to surgical treatment. Analysis of 115 patients.
    Sidhu GS; Koss LG; Barber RK
    Obstet Gynecol; 1970 Mar; 35(3):329-38. PubMed ID: 5416699
    [No Abstract]   [Full Text] [Related]  

  • 36. Primary double invasive cervical carcinoma, squamous cell carcinoma and adenocarcinoma--case report.
    Vasiljevic M; Stanimirovic B; Stanojevic D; Djukic M; Vasiljevic N
    Eur J Gynaecol Oncol; 2008; 29(4):411-3. PubMed ID: 18714584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors in node-positive patients with stage IB-IIB cervical cancer treated by radical hysterectomy and pelvic lymphadenectomy.
    Kodama J; Seki N; Ojima Y; Nakamura K; Hongo A; Hiramatsu Y
    Int J Gynaecol Obstet; 2006 May; 93(2):130-5. PubMed ID: 16563395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors of pelvic lymph node metastasis in cervical adenocarcinoma following radical hysterectomy and pelvic lymphadenectomy.
    Yanaranop M; Sathapornteera N; Nakrangsee S
    J Med Assoc Thai; 2014 Nov; 97 Suppl 11():S87-95. PubMed ID: 25509701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Radical hysterectomy with pelvic lymphadenectomy in patients with carcinoma of the uterine cervix--3 years' experience].
    Bosković V; Glisić A; Petković S
    Srp Arh Celok Lek; 1998; 126(5-6):183-7. PubMed ID: 9863378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy.
    Ayhan A; Al RA; Baykal C; Demirtas E; Ayhan A; Yüce K
    Int J Gynecol Cancer; 2004; 14(2):286-92. PubMed ID: 15086728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.